![]() |
|
|
Food Components and Health Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705
* To whom correspondence should be addressed. E-mail: david.baer{at}ars.usda.gov.
Diabetes mellitus and its sequelae are a major and growing public health problem. The prevalence of diabetes worldwide is 194 million persons, or 5.1% of the population, and is projected to increase to 333 million, or 6.3% of the population, by 2025. Type 2 diabetes accounts for
90–95% of those with diabetes in the United States and other developed countries. Tea is the most widely consumed beverage in the world, second only to water. Tea contains polyphenols and other components that may reduce the risk of developing chronic diseases such as cardiovascular disease and cancer. Some evidence also shows that tea may affect glucose metabolism and insulin signaling, which, as a result, has spurred interest in the health effects of tea consumption on diabetes. Epidemiologic studies suggest some relation between tea consumption and a reduced risk of type 2 diabetes, although the mechanisms for these observations are uncertain. Findings from in vitro and animal models suggest that tea and its components may influence glucose metabolism and diabetes through several mechanisms, such as enhancing insulin sensitivity. Some human clinical studies evaluating tea and its components show improvement in glucoregulatory control and endothelial function. However, further controlled clinical trials are required to gain a better understanding of the long-term effects of tea consumption in persons with diabetes.
This article has been cited by other articles:
![]() |
L. Arab and J. B. Blumberg Proceedings of the Fourth International Scientific Symposium on Tea and Human Health. September 18, 2007. Washington, DC, USA. J. Nutr., August 1, 2008; 138(8): 1526S - 1588S. [Full Text] [PDF] |
||||
![]() |
S. M. Henning, J. J. Choo, and D. Heber Nongallated Compared with Gallated Flavan-3-ols in Green and Black Tea Are More Bioavailable J. Nutr., August 1, 2008; 138(8): 1529S - 1534S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Auger, W. Mullen, Y. Hara, and A. Crozier Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy J. Nutr., August 1, 2008; 138(8): 1535S - 1542S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. O. Song and O. K. Chun Tea Is the Major Source of Flavan-3-ol and Flavonol in the U.S. Diet J. Nutr., August 1, 2008; 138(8): 1543S - 1547S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuriyama The Relation between Green Tea Consumption and Cardiovascular Disease as Evidenced by Epidemiological Studies J. Nutr., August 1, 2008; 138(8): 1548S - 1553S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grassi, A. Aggio, L. Onori, G. Croce, S. Tiberti, C. Ferri, L. Ferri, and G. Desideri Tea, Flavonoids, and Nitric Oxide-Mediated Vascular Reactivity J. Nutr., August 1, 2008; 138(8): 1554S - 1560S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. W. Arts A Review of the Epidemiological Evidence on Tea, Flavonoids, and Lung Cancer J. Nutr., August 1, 2008; 138(8): 1561S - 1566S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Hakim, H.-H. S. Chow, and R. B. Harris Green Tea Consumption Is Associated with Decreased DNA Damage among GSTM1-Positive Smokers Regardless of Their hOGG1 Genotype J. Nutr., August 1, 2008; 138(8): 1567S - 1571S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kelly, M. Gomez-Ramirez, J. L. Montesi, and J. J. Foxe L-Theanine and Caffeine in Combination Affect Human Cognition as Evidenced by Oscillatory alpha-Band Activity and Attention Task Performance J. Nutr., August 1, 2008; 138(8): 1572S - 1577S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mandel, T. Amit, L. Kalfon, L. Reznichenko, and M. B. H. Youdim Targeting Multiple Neurodegenerative Diseases Etiologies with Multimodal-Acting Green Tea Catechins J. Nutr., August 1, 2008; 138(8): 1578S - 1583S. [Abstract] [Full Text] [PDF] |
||||